Leaflet MYDRANE 0.2mg / 3.1mg / 10mg / ml solution for injection
Indicated for: nasal congestion; rhinitis
Route of administration: injectable
Substance: tropicamide + phenylephrine + lidocaine (mydriatic + adrenergic decongestant + local anesthetic)
ATC: S01FA56 (Sensory organs | Mydriatics and cycloplegics | Anticholinergics)
This medicine may cause dizziness or vertigo.
Use caution if you have glaucoma or increased eye pressure.
May cause dry mouth, constipation, urinary retention, or blurred vision.
Older people may have an increased risk of side effects.
This medicine may increase the risk of heart rhythm disturbances.
Tropicamide+phenylephrine+lidocaine is a combination of medications used in ophthalmology for pupil dilation (mydriasis) and local anesthesia during diagnostic or surgical procedures. Tropicamide is a muscarinic receptor antagonist that relaxes the iris muscles, phenylephrine is an alpha-adrenergic agonist that contracts the iris dilator muscles, and lidocaine is a local anesthetic that reduces pain.
This combination is administered as ophthalmic drops, as directed by a physician. It is commonly used in fundus examinations, cataract surgery, or other ophthalmic interventions.
Common side effects include a burning or stinging sensation in the eye, dry eyes, and temporary photophobia. In rare cases, allergic reactions or temporary increases in intraocular pressure may occur.
Tropicamide+phenylephrine+lidocaine is an effective and safe combination for use in ophthalmology, helping to improve patient comfort and facilitate medical procedures.
General data about MYDRANE 0.2mg / 3.1mg / 10mg / ml
- Substance: tropicamide + phenylephrine + lidocaine
- Date of latest medicines list: 01-06-2026
- Product code: W62116002
- Concentration: 0.2mg / 3.1mg / 10mg / ml
- Pharmaceutical form: solution for injection
- Quantity: 20
- Product type: Original
- Price: 817.61 RON
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.